Who Has Used Internal Company Documents for Biomedical and Public Health Research and Where Did They Find Them?

Abstract

ObjectiveTo describe the sources of internal company documents used in public health and healthcare research.MethodsWe searched PubMed and Embase for articles using internal company documents to address a research question about a health-related topic. Our primary interest was where authors obtained internal company documents for their research. We also extracted information on type of company, type of research question, type of internal documents, and funding source.ResultsOur searches identified 9,305 citations of which 357 were eligible. Scanning of reference lists and consultation with colleagues identified 4 additional articles, resulting in 361 included articles. Most articles examined internal tobacco company documents (325/361; 90%). Articles using documents from pharmaceutical companies (20/361; 6%) were the next most common. Tobacco articles used documents from repositories; pharmaceutical documents were from a range of sources. Most included articles relied upon internal company documents obtained through litigation (350/361; 97%). The research questions posed were primarily about company strategies to promote or position the company and its products (326/361; 90%). Most articles (346/361; 96%) used information from miscellaneous documents such as memos or letters, or from unspecified types of documents. When explicit information about study funding was provided (290/361 articles), the most common source was the US-based National Cancer Institute. We developed an alternative and more sensitive search targeted at identifying additional research articles using internal pharmaceutical company documents, but the search retrieved an impractical number of citations for review.ConclusionsInternal company documents provide an excellent source of information on health topics (e.g., corporate behavior, study data) exemplified by articles based on tobacco industry documents. Pharmaceutical and other industry documents appear to have been less used for research, indicating a need for funding for this type of research and well-indexed and curated repositories to provide researchers with ready access to the documents.

Tobacco Industry Promotions and Pricing After Tax Increases: An Analysis of Internal Industry Documents

“…We searched the Truth Tobacco Industry Documents Library, 32 which contains over 14 million related to the industry, between January and May 2018 using established snowball methods. [33][34][35][36][37][38] Original searches focused on keywords (e.g. tax differential, border store) combined with delimiters like the names of individual states.…”

Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the MUDS study)

“…While they are currently available upon request from the European Medicines Agency for drugs submitted for approval, the FDA does not make CSRs publicly available . Many CSRs are available through unsealed litigation documents and other sources . We recommend that you use CSRs when possible, even when trials have been reported in public sources (eg, journal articles), and that you search for and request CSRs from manufacturers for all trials of drugs, biologics, and medical devices.…”

Tobacco manufacturer lobbying to undercut minimum price laws: an analysis of internal industry documents

“…Between June 2018 and July 2019, we searched the Truth Tobacco Industry Documents Library34 using established snowball methods 36–41. We began with ‘minimum price’ and ‘unfair cigarette sales’; searches were refined using names of states, corporate departments and employees, campaigns by date and materials identified from nearby documents using Bates numbers.…”